
Rep. Debbie Wasserman Schultz @RepDWStweets
Ibrance is a groundbreaking medication used to treat breast cancer, but at $69k a year it’s out of reach for most Americans. That’s why I just voted to pass #HR3 and lower the cost of Ibrance by 65%! https://t.co/p552LCWci9 — PolitiTweet.org